J. Watson

Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response

M. Schweiger, D. O’Riordain, L. Inamdar, 2004, European Respiratory Journal.

Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries

T. Collyns, C. Mullarkey, J. Watson, 2009, Thorax.

Use of QuantiFERON-TB Gold test in the investigation of unexplained positive tuberculin skin tests.

E. Nsutebu, M. Schweiger, T. Collyns, 2008, Public health.

Risk factors and medical follow-up of drug users tested for hepatitis C--can the risk of transmission be reduced?

M. Bassendine, E. Gilvarry, M. Serfaty, 1997, Drug and alcohol review.

Hepatitis C virus: epidemiology and genotypes in the north east of England.

P. Simmonds, A. Burt, F. K. Gould, 1996, Gut.